Reed John C
SEC-identified person · CIK 1181561 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Johnson & Johnson JNJ | EVP, Pharmaceuticals R&D | filed 2023 - 2026 |
| Isis Pharmaceuticals INC ISIS | Director | filed 2006 - 2012 |
| Clovis Oncology, Inc. CLVS | Director | filed 2011 - 2012 |
| Zonagen INC ZONA | Director | filed 2008 - 2009 |
| Pharmion Corp PHRM | Director | filed 2006 - 2008 |
| Stratagene Corp STGN | Director | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.